Navigation Links
Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Feb. 20, 2013 /PRNewswire/ -- New wound care technologies that detect early wound healing and manage wound healing mechanisms are finding favor with physicians that are trying to determine suitable treatment protocols. Wound care management received a thrust from cost-effective and efficient technologically advanced products and therapies. Some wound care advancements that gained traction recently include wound dressings that offer controlled release of enzymes and antimicrobial agents, and silver nanocomposites that exhibit protective barrier and anti-inflammatory properties.

New analysis from Frost & Sullivan's ( Wound Care Management Technologies research finds that wound care therapy developers are increasingly responding to the demand for more effective wound care solutions. Biotechnology, biomaterial, and tissue engineering-enabled innovations are some of the fastest growing technology segments in this market.

If you are interested in more information on this research, please email Britni Myers , Corporate Communications, at, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

Other popular innovations in wound management include honey-based dressings with antimicrobial, wound cleansing, and pain-free debridement properties, as well as tissue engineering constructs to promote wound healing. Combination medical devices that help deliver targeted wound care therapy to ensure safe and timely closure of wounds are also in demand.

Wound care specialists and podiatrists as well as general, vascular and orthopedic surgeons prefer cost-effective wound care solutions, while chronic wound patients and their caregivers seek faster and long-lasting wound healing solutions. Reacting to customer demand, manufacturers are adopting best practices to design wound dressings that provide tight control over the dressing's adsorption and fluid handling properties.

There is a surge in the number of wound healing technology platforms awaiting commercialization and multiple start-up firms and spin-offs from academia are working on procuring funds and partnerships for commercialization. Both Tier 1 and emerging companies are engaged in intense R&D to develop dressings that accelerate healing.

"Emerging companies that focus on every type of wound at each phase of the wound healing process will be able to provide innovative solutions," noted Frost & Sullivan Technical Insights Industry Analyst Prasanna Vadhana Kannan. "One of the noteworthy wound care solutions are advanced wound dressings that can assist in the complex task of tissue repair and efficiently remove bacterial biofilm formation."

Currently, there are no national or international standards to guide wound care dressing manufacturers, and the type of protocol adopted depends upon the physician's recommendation and patient's demand. This situation hinders the implementation and testing of affordable wound care platforms.

Standardization is vital since wound treatment relies heavily on proper wound bed preparation, the choice of wound dressings, and the patient's condition. Wound closure also depends on the use of appropriate products.

Researchers are striving to examine the importance of cell differentiation and tissue morphogenesis-based factors in faster wound healing. Manufacturers need greater clinical evidence to understand biological-mediated therapies and their role in improving the outcome of wound care.

"On the back of considerable research, wound care solutions are expected to have the capabilities to safeguard cells from apoptosis, and simultaneously stimulate rapid cell division and proliferation," noted Kannan. "A rising desire to achieve tissue regeneration rather than just wound closure encourages manufacturers to explore additional applications of wound healing technologies."

Connect with Frost & Sullivan on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

Wound Care Management Technologies, a part of the Technical Insights subscription, analyzes advances in the application of silver in microbial prophylaxis and treatment, advanced wound dressings and skin substitutes, biologic wound products, and hyperbaric oxygen as an adjunctive wound care treatment. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters and research services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360-degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Wound Care Management Technologies

Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lentigen Receives U.S. Orphan Drug Designation for Novel Gene Therapy for glioblastoma multiforme
2. Novelos Therapeutics Prices $5.5 Million Public Offering
3. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
4. RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug Compounds
5. Frost & Sullivan Determines a Real and Urgent Need for Novel Cancer Diagnostics Tests
6. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
7. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
8. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015
9. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
10. Insero Health Completes Phase I Trial of Novel Therapy in Patients With Drug Resistant Epilepsy
11. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... and the University of British Columbia suggested that laws requiring bicyclists to wear helmets ... that part of the reason for the controversial conclusion is that, while helmets have ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... the Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its ... exclusive list of CAAHEP accredited colleges, as only one of twelve colleges and universities ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... abuse located in central Michigan, have come together on Thanksgiving Day to share ... video, available for viewing on the Serenity Point YouTube channel, patients displayed what ...
Breaking Medicine News(10 mins):